Volume 5, Number 6—December 1999
Research
Epidemiologic Studies of Cyclospora cayetanensis in Guatemala
Table 2
Age group of participants | |||
---|---|---|---|
Characteristic | <5 years (n = 32) | >5 years (n = 30) | p |
Days of illness | 15 (3-76)a | 10 (2-90)a | 0.05b |
Stools per day | 5 (1-10)a | 3 (1-20)a | 0.04b |
Stool consistency | nsc | ||
Liquid/watery | 22 (69) | 18 (60) | |
Semisolid | 10 (31) | 6 (20) | |
Solid | 0 (0) | 4 (13) | |
Blood in stool | 7 (22) | 1 (3) | 0.05 |
Mucus in stool | 29 (91) | 11 (37) | <0.001 |
Fever | 24 (75) | 9 (30) | <0.001 |
Vomiting | 16 (50) | 8 (27) | ns |
Abdominal pain | 10 (31) | 13 (43) | ns |
Anorexia | 8 (25) | 7 (23) | ns |
Headache | 2 (6) | 7 (23) | ns |
Treated before | |||
visiting health-care | |||
facility with | |||
Any antibiotic | 22 (69) | 15 (50) | ns |
Metronidazole | 11 (34) | 9 (30) | ns |
Cotrimoxazole | 1 (3) | 4 (13) | ns |
Mebendazole | 7 (22) | 2 (7) | ns |
or albendazole |
aMedian (range).
bBy Wilcoxon 2-sample test
cns = not significant.
Page created: December 15, 2010
Page updated: December 15, 2010
Page reviewed: December 15, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.